A potential therapy for one of the leading causes of heart disease
(Gladstone Institutes) After 15 years of unrelenting work, a team of scientists from Gladstone Institutes has discovered a potential drug candidate for heart valve disease that works in both human cells and animals and is ready to move toward a clinical trial. Their findings were just published in the journal Science.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cardiology | Clinical Trials | Heart | Heart Disease | Heart Valve Disease | Heart Valves | International Medicine & Public Health | Science